AD—Alzheimer’s disease |
ALS—Amyotrophic lateral sclerosis |
Bcl-2—B-cell lymphoma 2 |
BiP/GRP78—Binding immunoglobulin protein/Glucose response protein 78 |
Ca2+—Calcium |
CMT—Charcot–Marie–Tooth |
Drp-1—Dynamin -related protein |
EMRE—Essential MCU regulator |
FRDA—Friedreich’s ataxia |
GDAP1—Ganglioside-induced associated protein 1 |
GRP75—Glucose-regulated protein 75 |
GSH—Glutathione |
H2O2—Hydrogen peroxide |
HD—Huntington’s disease |
IMM—Inner mitochondrial membrane |
IP3R—Inositol 1,4,5-trisphosphate receptor |
MAMs—Endoplasmic reticulum–mitochondria-associated membranes |
MCU/Mcu—Mitochondrial calcium uniporter |
MCUb—Mitochondrial calcium uniporter regulatory subunit |
MCUR1—Mitochondrial calcium uniporter regulator 1 |
MFN2—Mitofusin 2 |
MICU1/2/3—Mitochondrial calcium uptake protein 1, 2, 3 |
MiCUps—Mitochondrial Ca2+ uptake enhancers |
NGF—Nerve Growth Factor |
NRF2—Nuclear factor erythroid 2-related factor 2 |
OMM—Outer mitochondrial membrane |
PD—Parkinson’s disease |
ROS—Reactive oxygen species |
RyR—Ryanodine receptor |
SCA2/3—Spinocerebellar ataxias type 2 and 3 |
Sig-1R—Sigma non-opioid intracellular receptor 1 |
SOD1—Superoxide dismutase 1 |
SOD2—Superoxide dismutase 2 |
SR/ER—Sarcoplasmic/endoplasmic reticulum |
VDAC—Voltage-dependent anion channel |
|